|
Let''s Move/HHS Healthy Weight Task Force
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIDDK, NHLBI
|
The HHS Healthy Weight Task Force aims to improve dietary and physical activity behaviors through targeted sector initiatives
|
|
Long-term Oxygen Treatment Trial
|
Research Initiative
|
CMS
|
NHLBI
|
The Long-term Oxygen Treatment Trial is a randomized controlled clinical trial to assess the efficacy of around-the-clock, supplemental oxygen therapy in subjects with chronic obstructive pulmonary disease and moderately severe hypoxemia. NHLBI will administer and oversee the study, and Medicare will cover the costs of items and medical services that are generally available through that program to beneficiaries enrolled in the trial.
|
|
Lupus Federal Working Group
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, OS
|
NIAMS, NCCAM, NEI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIMHD, NINDS
|
The Lupus Federal Working Group, established on behalf of the HHS Secretary by the NIH, facilitates collaboration among NIH components, other Federal agencies, voluntary and professional organizations, and industry groups with an interest in lupus. These agencies exchange information on new developments and take advantage of new scientific opportunities in the field of lupus research.
|
|
Malaria Transmission
|
Research Initiative
|
FDA
|
NIAID
|
This collaboration is designed to develop new ways of detecting malaria parasites in mosquitoes to facilitate studies of transmission blocking.
|
|
Maternal and Child Health (MCH) Research Pediatric Practice Based Research Network (PBRN) Initiative
|
Research Initiative
|
HRSA
|
NICHD
|
This Intra-Departmental Delegation of Authority (IDDA) provides money to HRSA to fund the following activities: Electronic Health Record (EHR) Pediatric Practice Based Research Network (PBRN) Initiative; and Comparative Effectiveness Research (CER) and epidemiologic assessments of the use of selected psychotropic medications and the most commonly prescribed asthma medications in pediatric populations, as well as the possible association between these medications and side effects in this population.
|
|
Medical Education Partnership Initiative (MEPI)
|
Training Initiative
|
CDC, HRSA
|
FIC, NCATS, NCCAM, NCI, NHGRI, NHLBI, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OAR, OD/DPCPSI/ORWH, OD/DPCPSI/OSC
|
The Medical Education Partnership Initiative (MEPI) supports foreign institutions in Sub-Saharan African countries that receive PEPFAR support and their partners to develop or expand and enhance models of medical education. These models are intended to support PEPFAR’s goal of increasing the number of new health care workers by 140,000, strengthen medical education systems in the countries in which they exist, and build clinical and research capacity in Africa as part of a retention strategy for faculty of medical schools and clinical professors.
|
|
Medical Expenditure Panel Survey (MEPS)
|
Health Survey
|
AHRQ
|
NCI
|
The Medical Expenditure Panel Survey (MEPS) is a set of large-scale surveys of families and individuals, their medical providers, and employers across the United States. MEPS is the most complete source of data on the cost and use of health care and health insurance coverage.
|
|
Medical Planning and Response to a Nuclear Detonation Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NCI
|
This group developed educational materials related to emergency planning for nuclear detonations for government use and publication.
|
|
Medicare benefit postcard developed by NEI and CMS
|
Public Education Campaign
|
CMS
|
NEI
|
NEI worked with CMS to develop and disseminate a Medicare benefit card in English and Spanish which describes eligibility for the Medicare benefit for glaucoma and diabetic eye disease. The postcards are distributed to Medicare beneficiaries, the general public, and to health professionals.
|
|
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
This Memorandum of Understanding (MOU) provides a mechanism for addressing cross-cutting issues related to therapy development for neurological disorders, from bench science to clinical trials and FDA approval and licensure.
|